Figure 7.
SLC16A10 mediates the anti-inflammatory effect of miR-21-5p. (A) A549 cells were co-transfected with miR-21-5p inhibitor and si-SLC16A10, and the mRNA levels of SLC16A10, IL-1β and TNF-α were measured by RT-qPCR in six groups. including the control group, LPS, LPS + NC inhibitor, LPS + miR-21-5p inhibitor, LPS + miR-21-5p inhibitor + NC siRNA, LPS + miR-21-5p inhibitor + si-SLC16A10 (n = 3). (B) Western blot further verified the expression levels of SLC16A10, IL-1β and TNF-α in six groups. (C) Quantification analysis of protein expression levels of SLC16A10, IL-1β and TNF-α (n = 3). All data are shown as the mean ± SEM. ****P ≤ 0.0001, ***P ≤ 0.001, **P < 0.01, *P < 0.05; NS, not significant (P > 0.05).
